![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CYP20A1 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Cyp20a1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP20A1 mRNA | CTD | PMID:36331819 | CYP20A1 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Cyp20a1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CYP20A1 mRNA | CTD | PMID:22206623 | CYP20A1 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Cyp20a1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CYP20A1 mRNA | CTD | PMID:22206623 | CYP20A1 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Cyp20a1 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | CYP20A1 | Human | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Cyp20a1 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | CYP20A1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cyp20a1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CYP20A1 mRNA | CTD | PMID:21570461 | CYP20A1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP20A1 mRNA | CTD | PMID:33387578 and PMID:34747641 | CYP20A1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Cyp20a1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP20A1 mRNA | CTD | PMID:28213091 | CYP20A1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Cyp20a1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP20A1 gene] | CTD | PMID:28213091 | CYP20A1 | Human | 2,4-dinitrotoluene | affects expression | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of CYP20A1 mRNA | CTD | PMID:21346803 | CYP20A1 | Human | 2,6-dinitrotoluene | affects expression | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of CYP20A1 mRNA | CTD | PMID:21346803 | CYP20A1 | Human | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of CYP20A1 mRNA | CTD | PMID:37199045 | CYP20A1 | Human | 4-hydroxyphenyl retinamide | decreases expression | ISO | Cyp20a1 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of CYP20A1 mRNA | CTD | PMID:28973697 | CYP20A1 | Human | 5-aza-2'-deoxycytidine | affects expression | EXP | | 6480464 | Decitabine affects the expression of CYP20A1 mRNA | CTD | PMID:23300844 | CYP20A1 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of CYP20A1 mRNA | CTD | PMID:30047161 | CYP20A1 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of CYP20A1 mRNA | CTD | PMID:33167477 | CYP20A1 | Human | amitrole | increases expression | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of CYP20A1 mRNA | CTD | PMID:30047161 | CYP20A1 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of CYP20A1 mRNA | CTD | PMID:33212167 | CYP20A1 | Human | arsane | decreases expression | ISO | Cyp20a1 (Mus musculus) | 6480464 | Arsenic results in decreased expression of CYP20A1 mRNA | CTD | PMID:19654921 | CYP20A1 | Human | arsenic atom | decreases expression | ISO | Cyp20a1 (Mus musculus) | 6480464 | Arsenic results in decreased expression of CYP20A1 mRNA | CTD | PMID:19654921 | CYP20A1 | Human | benzo[a]pyrene | increases expression | ISO | Cyp20a1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CYP20A1 mRNA | CTD | PMID:22228805 | CYP20A1 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of CYP20A1 exon and Benzo(a)pyrene results in increased methylation of CYP20A1 promoter | CTD | PMID:27901495 | CYP20A1 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CYP20A1 mRNA | CTD | PMID:25047013 | CYP20A1 | Human | bisphenol A | increases methylation | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of CYP20A1 gene | CTD | PMID:28505145 | CYP20A1 | Human | bisphenol A | decreases expression | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CYP20A1 mRNA | CTD | PMID:30816183 more ... | CYP20A1 | Human | bisphenol A | increases expression | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of CYP20A1 mRNA | CTD | PMID:25181051 | CYP20A1 | Human | bisphenol F | increases expression | ISO | Cyp20a1 (Mus musculus) | 6480464 | bisphenol F results in increased expression of CYP20A1 mRNA | CTD | PMID:38685157 | CYP20A1 | Human | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of CYP20A1 mRNA | CTD | PMID:26079696 | CYP20A1 | Human | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CYP20A1 mRNA | CTD | PMID:35301059 | CYP20A1 | Human | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CYP20A1 mRNA | CTD | PMID:35301059 | CYP20A1 | Human | carnosic acid | decreases expression | ISO | Cyp20a1 (Mus musculus) | 6480464 | salvin results in decreased expression of CYP20A1 protein | CTD | PMID:35926579 | CYP20A1 | Human | chromium(6+) | affects expression | ISO | Cyp20a1 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of CYP20A1 mRNA | CTD | PMID:28472532 | CYP20A1 | Human | cisplatin | affects expression | EXP | | 6480464 | Cisplatin affects the expression of CYP20A1 mRNA | CTD | PMID:23300844 | CYP20A1 | Human | crocidolite asbestos | decreases expression | EXP | | 6480464 | Asbestos and Crocidolite results in decreased expression of CYP20A1 mRNA | CTD | PMID:25351596 | CYP20A1 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of CYP20A1 mRNA | CTD | PMID:20106945 and PMID:25562108 | CYP20A1 | Human | diethylstilbestrol | decreases expression | EXP | | 6480464 | Diethylstilbestrol results in decreased expression of CYP20A1 mRNA | CTD | PMID:36621641 | CYP20A1 | Human | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of CYP20A1 mRNA | CTD | PMID:26615145 | CYP20A1 | Human | finasteride | increases expression | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | Finasteride results in increased expression of CYP20A1 mRNA | CTD | PMID:24136188 | CYP20A1 | Human | fipronil | increases expression | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | fipronil results in increased expression of CYP20A1 mRNA | CTD | PMID:23962444 | CYP20A1 | Human | fipronil | decreases expression | EXP | | 6480464 | fipronil results in decreased expression of CYP20A1 mRNA | CTD | PMID:27091632 | CYP20A1 | Human | fipronil | multiple interactions | EXP | | 6480464 | [fipronil co-treated with DEET] results in decreased expression of CYP20A1 mRNA | CTD | PMID:27091632 | CYP20A1 | Human | flutamide | increases expression | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of CYP20A1 mRNA | CTD | PMID:24136188 | CYP20A1 | Human | folic acid | multiple interactions | ISO | Cyp20a1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CYP20A1 mRNA | CTD | PMID:22206623 | CYP20A1 | Human | gallic acid | decreases expression | EXP | | 6480464 | Gallic Acid results in decreased expression of CYP20A1 mRNA | CTD | PMID:34408198 | CYP20A1 | Human | gentamycin | increases expression | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of CYP20A1 mRNA | CTD | PMID:33387578 | CYP20A1 | Human | hypochlorous acid | increases expression | ISO | Cyp20a1 (Mus musculus) | 6480464 | Hypochlorous Acid results in increased expression of CYP20A1 mRNA | CTD | PMID:19376150 | CYP20A1 | Human | methapyrilene | decreases expression | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | Methapyrilene results in decreased expression of CYP20A1 mRNA | CTD | PMID:30467583 | CYP20A1 | Human | methimazole | increases expression | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of CYP20A1 mRNA | CTD | PMID:30047161 | CYP20A1 | Human | methoxychlor | affects methylation | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of CYP20A1 gene | CTD | PMID:35440735 | CYP20A1 | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of CYP20A1 mRNA | CTD | PMID:23649840 | CYP20A1 | Human | monosodium L-glutamate | increases expression | ISO | Cyp20a1 (Mus musculus) | 6480464 | Sodium Glutamate results in increased expression of CYP20A1 mRNA | CTD | PMID:22078008 | CYP20A1 | Human | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [fipronil co-treated with DEET] results in decreased expression of CYP20A1 mRNA | CTD | PMID:27091632 | CYP20A1 | Human | nefazodone | increases expression | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | nefazodone results in increased expression of CYP20A1 mRNA | CTD | PMID:24136188 | CYP20A1 | Human | nimesulide | increases expression | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | nimesulide results in increased expression of CYP20A1 mRNA | CTD | PMID:24136188 | CYP20A1 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CYP20A1 mRNA | CTD | PMID:22230336 | CYP20A1 | Human | paracetamol | increases expression | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of CYP20A1 mRNA | CTD | PMID:33387578 | CYP20A1 | Human | PCB138 | multiple interactions | ISO | Cyp20a1 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | CYP20A1 | Human | pentachlorophenol | decreases expression | ISO | Cyp20a1 (Mus musculus) | 6480464 | Pentachlorophenol results in decreased expression of CYP20A1 mRNA | CTD | PMID:23892564 | CYP20A1 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Cyp20a1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP20A1 mRNA | CTD | PMID:36331819 | CYP20A1 | Human | phenobarbital | increases expression | ISO | Cyp20a1 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of CYP20A1 mRNA | CTD | PMID:19270015 | CYP20A1 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of CYP20A1 mRNA | CTD | PMID:25351596 | CYP20A1 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of CYP20A1 mRNA | CTD | PMID:38568856 | CYP20A1 | Human | succimer | multiple interactions | ISO | Cyp20a1 (Mus musculus) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP20A1 mRNA | CTD | PMID:26378955 | CYP20A1 | Human | sulfadimethoxine | increases expression | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of CYP20A1 mRNA | CTD | PMID:30047161 | CYP20A1 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of CYP20A1 mRNA | CTD | PMID:31533062 | CYP20A1 | Human | tetrachloromethane | decreases expression | ISO | Cyp20a1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of CYP20A1 mRNA | CTD | PMID:17484886 | CYP20A1 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CYP20A1 mRNA | CTD | PMID:29154799 | CYP20A1 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of CYP20A1 mRNA | CTD | PMID:25979313 | CYP20A1 | Human | vinclozolin | decreases expression | ISO | Cyp20a1 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of CYP20A1 mRNA | CTD | PMID:23869203 | |